VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3529
-0.0127 (-3.47%)
At close: Aug 1, 2025, 4:00 PM
0.3550
+0.0021 (0.60%)
After-hours: Aug 1, 2025, 7:58 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Chronic Inflammatory and Immune-mediated Therapies
501.00K
Log In
Log In
Log In
Log In
Upgrade
Chronic Inflammatory and Immune-mediated Therapies Growth
18.16%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
501.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
18.16%
Log In
Log In
Log In
Log In
Upgrade